You’ve hit your search limit
Start your free trial to keep exploring full traffic and performance insights.
Get StartedALDS analisi dell'app per 18 gennaio
ALDS
- LOTHAR MEDTEC GmbH
- App Store di Apple
- Gratis
- Salute e fitness
The Ambulatory Lung Diagnostic system's cloud-based algorithm evaluates the readings and uses the resulting clinical outcome parameters along with patient history data to provide physicians with a physiological interpretation of the results. The algorithm is based on published concepts for interpreting obstructive and restrictive patterns that indicate corresponding airway limitations. The ALDS is specifically designed for general practitioners and pediatricians in outpatient care. The system fulfills modern requirements for mobility and robustness to efficiently examine many patients per day. The typical duration of an examination is only a few minutes per patient and builds on oscillometry, which requires only normal breathing. Spirometry is available as an option, for example if oscillometry data indicate a possible restrictive airway limitation. The opportunity to combine both tests provides a more comprehensive and multidimensional evaluation of a patient's lung function.
Classifica degli store
La classifica del store si basa su diversi parametri stabiliti da Google e Apple.
Tutte le categorie in
Stati Uniti--
Salute e fitness in
Stati Uniti--
Crea un account per visualizzare il numero mensile medio di downloadContattaci
ALDSStatistiche di ranking nel tempo
Classifica di Utilizzo di Similarweb e Classifica App Store di Apple per ALDS
Rank
Nessun dato disponibile
ALDS Classifica per paese
Paesi in cui ALDS ha la posizione più alta nelle sue categorie principali
Nessun dato da visualizzare
Principali concorrenti e app alternative
App con un'alta probabilità di essere utilizzate dagli stessi utenti, provenienti dallo stesso store.
VitalFlo Health
VitalFlo, Inc.
VitaScale Coach
Vitascale GmbH
FlowPeak
IMMIX CONCEPTS, LLC
SpiroClinic
INOFAB SAGLIK TEKNOLOJILERI ANONIM SIRKETI
gennaio 18, 2026